key: cord-1033142-5hyi8ryd authors: Waltenburg, M. A.; Pomeroy, M. A.; Hughes, L.; Gold, J. A. W.; Mayer, O.; Vang, A.; Hallowell, B. D.; Foster, L.; Xu, K.; Espinoza, R.; Hsieh, K.; Pieracci, E. G.; Wuyke, G.; Da Silva, J.; McClung, R. P.; Steinberg, J.; Westercamp, M.; Vallabhaneni, S.; Li, J.; Valderrama, A. L.; Grimes, G. R.; Harvey, R. R.; Nett, R. J.; Stokes, K.; Lindstrom, S.; Miller, A. D.; Griggs, E. P.; Milucky, J. L.; Bjork, A.; Albrecht, V.; Kuhnert, W. L.; Gould, C. V.; Knight, N. W.; Nelson, N. P.; Honein, M. A.; Barton Behravesh, C.; CDC COVID-19 Investigation Team,; Dubray, C. L.; Marx, G. E. title: Testing for SARS-CoV-2 among cruise ship travelers repatriated to the United States, February to March 2020 date: 2021-06-09 journal: nan DOI: 10.1101/2021.06.07.21258318 sha: 946a4ca9a3bc9add222019f4b55b6221abd900a1 doc_id: 1033142 cord_uid: 5hyi8ryd Background: In early 2020, an outbreak of coronavirus disease 2019 occurred among passengers and crew of the Diamond Princess cruise ship. During February 16 and 17, some US citizens, residents, and their partners voluntarily repatriated to the US from Japan. Methods: We conducted a retrospective, longitudinal evaluation of repatriated travelers where the outcome of interest was a positive test for SARS-CoV-2. Travelers who tested positive for SARS-CoV-2 were isolated in hospitals or at home under county isolation orders and underwent serial testing by real-time reverse transcription polymerase chain reaction (RT-PCR) approximately every other day, as contemporaneous US guidance required two consecutive negative tests collected greater than or equal to 24 hours apart and symptom improvement before release from isolation. Results: Among quarantined repatriated travelers, 14% tested positive for SARS-CoV-2. One-fifth of infected travelers initially tested negative but were identified on subsequent testing. All infected travelers remained asymptomatic or developed mild symptoms during isolation. Many travelers remained in prolonged isolation because of persistent viral detection based on contemporaneous policies. Conclusion: Our findings support testing within 3-5 days after possible SARS-CoV-2 exposure to comprehensively identify infections and mitigate transmission and lend support to symptom- and time-based isolation recommendations, rather than test-based criteria. In early 2020, an outbreak of coronavirus disease 2019 (COVID-19) occurred among passengers and crew of the Diamond Princess cruise ship [1, 2] . During February 16-17, 329 US citizens, residents, and their partners (subsequently referred to as repatriated travelers) voluntarily repatriated to the US from Japan. Of those repatriated, 328 were quarantined under federal authority at US military bases; one traveler was not quarantined based on documentation of having recovered from COVID-19 in Japan [1, 2] . Travelers who tested positive for SARS-CoV-2, the virus that causes COVID-19, were isolated in hospitals or at home under county isolation orders and underwent serial testing by real-time reverse transcription polymerase chain reaction (RT-PCR) approximately every other day, as contemporaneous US guidance required two consecutive negative tests collected ≥24 hours apart and symptom improvement before release from isolation [3] . We report the RT-PCR results and symptom status of travelers to describe viral dynamics during mild or asymptomatic COVID-19 and to inform testing strategies after SARS-CoV-2 exposure. We conducted a retrospective, longitudinal evaluation of repatriated travelers; the outcome of interest was a positive test for SARS-CoV-2. Specimens were collected by oropharyngeal (OP) and/or nasopharyngeal (NP) swab and tested by RT-PCR for SARS-CoV-2 [4] . Available RT-PCR results were obtained from the Japanese Ministry of Health, Labour, and Welfare, the Centers for Disease Control and Prevention (CDC), and state public health laboratories. This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy. § We reviewed demographic and symptom data collected at the time of the first positive SARS-CoV-2 test. Demographic characteristics for travelers who tested positive for SARS-CoV-2 were compared All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 9, 2021. with travelers who tested negative; proportions for sex were compared using χ 2 test and age compared using the Mann-Whitney U test method. Travelers were categorized as asymptomatic, presymptomatic (no symptoms at time of first positive result but later developed symptoms), or symptomatic (at least one new or worsened symptom of COVID-19 at time of first positive result) [5] . Mild illness was defined as individuals with any sign or symptom of COVID-19 without shortness of breath, dyspnea, or abnormal chest imaging [6] . We calculated time to RT-PCR negativity (i.e., reversion to negative) as the number of days between the first positive RT-PCR test and the first of two consecutive negative tests on paired NP and OP specimens collected ≥24 hours apart. Intermittent viral shedding was defined as a positive RT-PCR test following a negative test. Cycle threshold (Ct) values for amplification of two targets (N1 and N2) of the viral nucleocapsid gene were analyzed for NP and OP specimens submitted to CDC (4). Specimens with Ct values <40 for both targets were considered positive for SARS-CoV-2 (4). Ct values for the N1 and N2 genetic markers were highly correlated (Appendix A); for simplicity, we reported Ct values for the N1 genetic marker. Of 328 quarantined repatriated travelers, 45 (14%) tested positive for SARS-CoV-2; all remained asymptomatic or developed mild symptoms during isolation. Among 45 travelers, 28 (62%) had a positive RT-PCR result in Japan before repatriation, 10 (22%) had negative results in Japan but then had a positive result in the US, and 7 (16%) who were never tested in Japan had a positive result in the US. The median time to test positivity after repatriation among the 10 travelers who tested negative in Japan was 3 days (range: 0-9). Demographic characteristics of repatriated travelers, regardless of test result, All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 9, 2021. ; were similar (Table 1) . Overall, 25 (56%) of 45 travelers were asymptomatic or presymptomatic at the time of first positive SARS-CoV-2 result. Results from 556 RT-PCR tests from 45 travelers who tested positive for SARS-CoV-2 were available for analysis. Median time to RT-PCR negativity for 30 travelers for whom two consecutive negative results were available was 17 days (range = 3-38). The proportion of these 30 travelers with reversion to negative at days 10, 14, and 21 after diagnosis was 30%, 43%, and 63%, respectively (Figure 1 ). Two consecutive negative results were not available for 15 travelers because of missing data after travelers were issued state or county isolation orders, or released from isolation according to updated US guidance that no longer required two consecutive negative results (3) Our findings support testing within 3-5 days after possible SARS-CoV-2 exposure to comprehensively identify infections and mitigate transmission [7] . Repeat testing in the US identified ten COVID-19 cases among repatriated travelers who had previously tested negative in Japan; most were asymptomatic or presymptomatic at the time of US testing, highlighting that symptom-based testing after possible SARS-CoV-2 exposure is not sufficient to identify all infections to prevent further transmission [8, 9] . During COVID-19 outbreaks in settings where rapid spread of SARS-CoV-2 is possible, testing, All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 9, 2021. ; https://doi.org/10.1101/2021.06.07.21258318 doi: medRxiv preprint irrespective of symptoms, should be considered to identify asymptomatic and presymptomatic infections [10, 11] . Universal adoption of risk mitigation strategies such as masks, hand hygiene, and physical distancing is important to prevent transmission from people who are infected but asymptomatic [9, 12, 13] . Most repatriated travelers in our analysis remained in isolation ≥21 days because of persistent viral detection based on contemporaneous policies [3] . Applying current symptom-and time-based guidance, these travelers would have been released from isolation 10 days after symptom onset or their first positive test; it is notable that only 30% of travelers had reverted to negative at 10 days [14] . Qualitative RT-PR tests do not measure viral load, although there is a likely inverse correlation between Ct value and the amount of viral genetic material present in the specimen [15] . The Ct value dynamics in this report substantiate prior findings that concentrations of SARS-CoV-2 RNA in upper respiratory specimens decline after initial diagnosis [12, 16] , as does the likelihood of recovering replicationcompetent virus from people who persistently shed SARS-CoV-2 RNA [16, 17] . Our analysis has several limitations. Our results are not likely to be representative of the general US population; our small sample size of repatriated travelers was generally older and did not include travelers with severe COVID-19 who were hospitalized in Japan. Comprehensive longitudinal symptom and laboratory data were not available for all travelers throughout isolation. Information on patientrelated factors (e.g., underlying health conditions) that might have influenced persistent viral shedding or low Ct values was not available. Ct values can be influenced by test-related factors, including specimen quality, reaction conditions, and amplification efficiency [15] . Viral culture data are needed to demonstrate the presence of replication-competent virus to determine the duration of shedding of viable virus and implications for risk of transmission. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 9, 2021. ; (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 9, 2021. ; https://doi.org/10.1101/2021.06.07.21258318 doi: medRxiv preprint All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 9, 2021. ; https://doi.org/10.1101/2021.06.07.21258318 doi: medRxiv preprint Ct values of N1 target in nasopharyngeal specimens All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 9, 2021. Ct values of N1 target in oropharyngeal specimens Days since first positive SARS-CoV-2 RT-PCR test All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 9, 2021. Public Health Reponses to COVID-19 Outbreaks on Cruise Ships -Worldwide Discontinuation of Isolation for Persons with COVID-19 Not in Healthcare Settings Centers for Disease Control and Prevention. CDC 2019-novel coronavirus (2019-nCoV) real-time RT-PCR diagnostic panel Centers for Disease Control and Prevention. Symptoms of Coronavirus Discontinuation of Transmission-Based Precautions and Disposition of Patients with COVID-19 in Healthcare Settings Centers for Disease Control and Prevention. COVID-19 and Cruise Ship Travel Prevalence of SARS-CoV-2 Infection in Residents of a The implications of silent transmission for the control of COVID-19 outbreaks CDC Guidance for Expanded Screening Testing to Reduce Silent Spread of SARS-CoV-2 Investigating and responding to COVID-19 cases at homeless service provider sites Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility Centers for Disease Control and Prevention. Managing Investigations During an Outbreak Discontinuation of Isolation for Persons with COVID-19 Not in Healthcare Settings SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and metaanalysis Findings from Investigation and Analysis of repositive cases Our findings illustrate the importance of timely testing after possible SARS-CoV-2 exposure and lend